Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers
Authors:
Open Access
- 1 August 2020
- journal article
- research article
- Published by Elsevier in European Urology Oncology
- Vol. 3 (4) , 548-554
Abstract
No abstract availableKeywords
Funding Information
- GlaxoSmithKline Australia
- Roche
- British Microcirculation & Vascular Biology Society
- Astellas Pharma
- Meso Scale Diagnostics
This publication has 22 references indexed in Scilit:
- Correlation Between Confocal Laser Endomicroscopy (Cellvizio®) and Histological Grading of Upper Tract Urothelial Carcinoma: A Step Forward for a Better Selection of Patients Suitable for Conservative ManagementEuropean Urology Focus, 2018
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016European Urology, 2017
- Upper Urinary Tract Carcinoma In Situ: Current Knowledge, Future DirectionJournal of Urology, 2017
- Guideline of guidelines: non‐muscle‐invasive bladder cancerBJU International, 2017
- Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO GuidelineJournal of Urology, 2016
- ICUD-EAU International Consultation on Bladder Cancer 2012: Screening, Diagnosis, and Molecular MarkersEuropean Urology, 2013
- Confocal Laser Endomicroscopy of Bladder Tumors Associated With Photodynamic Diagnosis: An Ex Vivo Pilot StudyUrology, 2012
- Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle‐invasive bladder cancer and negative cytologyCancer, 2011
- Surveillance for Recurrent Bladder Cancer Using a Point-of-Care Proteomic AssayJAMA, 2006
- A SIDE BY SIDE COMPARISON OF CYTOLOGY AND BIOMARKERS FOR BLADDER CANCER DETECTIONJournal of Urology, 2004